FDA Investigator Humera T Khan

Humera T Khan has inspections in 1 countries as of 31 Mar 2023. Humera T Khan has collaborated with a combinined 2701 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
31 Mar 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America
Adam J Taylor, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana L Kewes, Andrew A Leboeuf, Anna Flynn, Anthony R Ronga, Ashley L Reiber, Brentley S Collins, Brian D Nicholson, Bruce H Mccullough, Burnell M Henry, Carl A Huffman, III, Carlyn L Ray, Carrie Ann Plucinski, Chad E Schmear, Charlie P Booker, Cheryl A Kmiec, Chiang Syin, PhD, Christopher B Harding, Christopher D Leach, Claire M Minden, Clotia Cabbey Mensah, Daniel B Arrecis, Daniel C Kearns, Daniel Kearns, Darla J Christopher, David Perkins, Deborah M Trout, Debra Boyd Seale, Debra I Love, Debra L Boyd Seale, Denise L Burosh, Dr. Andrew Shroke, Dr. Guang Gao, PhD, Eliezar Ramos, Elliot P Cowam, PhD, Emily S Mcgann, Eric A Breselow, Eric M Mueller, PharmD, Eric S Pittman, Esther A Ofori, Gene D Arcy, Gregory Price, Harperd, Helen B Ricalde, Humera Khan, Ismael Olvera, IV, Jacqueline Mdiaz Albertini, James P Duggan, James W Plucinski, Jan B Welch, Jan Welch, Janae D Price, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer C Adams, Jennifer C Johnson, Jennifer L Schmidt, Jesse A Vazquez, Jesse P Romenesko, Jessica L Burley, Joan A Loreng, John A Iwen, John M Seale, Joseph A Morkunas, Julie D Bringger, Karen Emasley Joseph, Karen Emaslwey Joseph, Kathleen B Swat, Kathleen S Tormey, Kimberly Lewandowski Walker, Kristen E Szenderski, Kujtim Sadiku, Lagurta M Mayher, Lakisha M Williams, Lana K Waselewski, Laura Fontan, MS, Lauren A Crivellone, Laurie A Haxel, LCDR Debra Emerson, LCDR Randall L Morris, Leeterry Moore, Lequita M Mayhew, Lewis K Antwi, Liliya V Bubiy, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Lorelei S Jarrell, Margaret Mtorres Vazquez, Margaret Torres Vazquez, Mark I Kaspar, Martha T Olone, Maureen C Melvin, Melissa D Kalik, Melissa J Holz, Michael D Robinson, Michelle J Glembin, Mihaly S Ligmond, Mpris Inspector, Nicholas F Lyons, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Norman L Brown, Norman Wong, Omotunde O Osunsanmi, Pablo Alcantara, Patricia A Mcilroy, Phung Thien Nguyen, Prabhu P Raju, Rafael Padilla, Richard Heath Coats, Richard T Riggie, Robert L Stevenson, Roberta W Cunningham, Rosemary A Sexton, Roshni J Patel, Russell K Riley, Samuel W Labinjo, Sarah A Palmer, Sarah B Tanksley, Sarah L Roman, Sean R Bryd, Shana L Williams, Sherea L Dillon, State Agency, Stephanie A Wright, Stephen D Brown, Stephen D Eich, Sullan, Susan A Zullo, PhD, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tamara M Qtami, Tara C Alcazar, Tarsha T Mcclendon, Thomas J Arista, Thomas W Nojek, Thunder N Dunkijacobs, Todd M Stankewicz, Travis S Bradley, Unnee Ranjan, Uruaku A Obasi, William D Sherman, Yonggang Wang, PhD, Yvonne E Lozano, Zerita White

Humera T Khan's Documents

Publish Date Document Type Title
April, 2000 FDA 483 Response Abbott Laboratories - Form 483R, 2000-04-13
April, 2000 FDA 483 Response Abbott Laboratories - Form 483R, 2000-08-28
May, 2001 FDA 483 CSL Behring L.L.C. - Form 483, 2001-05-24
October, 2000 EIR Vitalant - EIR, 2000-10-13
October, 2000 FDA 483 Vitalant - Form 483, 2000-10-13
May, 2001 EIR CSL Behring L.L.C. - EIR, 2001-05-24
April, 2003 EIR CSL Behring L.L.C. - EIR, 2003-04-01
April, 2003 FDA 483 CSL Behring L.L.C. - Form 483, 2003-04-01
April, 2000 FDA 483 Abbott Laboratories - Form 483, 2000-03-31
October, 2000 FDA 483 Response Vitalant - Form 483R, 2000-11-30
April, 2000 EIR Abbott Laboratories - EIR, 2000-03-31
April, 2000 EIR Abbott Laboratories - EIR, 2000-04-10
May, 2002 EIR Oberweis Dairy, Inc. - EIR, 2002-05-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more